AACOMmunities

Federal Funding Opportunities and Resources

Below is a selected list of timely federal funding opportunities that are relevant to the osteopathic medical education community. AACOM updates this resource frequently.  Please bookmark the page for your reference. For a comprehensive listing of federal funding opportunities, please visit Grants.gov.   

Featured Opportunities

February 1 - February 14

Centers for Disease Control - NCCDPHP

Behavioral Risk Factor Surveillance System (BRFSS): Impact in Population Health

Estimated Application Due Date: May 29, 2020

CDC announces funds to implement the Behavioral Risk Factor Surveillance System (BRFSS): Impact in Population Health. CDC established the BRFSS in 1984 with 15 states participating in monthly data collection. Since that time, the BRFSS has grown to be the only continuous, state-based health surveillance system that is conducted nationwide. This funding would provide financial and technical assistance to recipients to conduct health-related behavioral surveillance through the BRFSS and increase the use of BRFSS data to inform public health actions to improve health.

January 21 – January 31

National Institutes of Health

Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional)

Letter of Intent Due: 30 days prior to due date

Application Due: Rolling basis beginning February 24

The purpose of this funding is to support the discovery and development of medications to prevent and treat opioid use disorders (OUD) and overdose.

HEAL Initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development (R61/R33 - Clinical Trial Not Allowed)

Letter of Intent Due: 30 days prior to due date

Application Due: March 24, 2020 (5:00 PM local to applicant organization)

This funding opportunity invites applications for pre-clinical research to develop novel, mechanism-based pharmacotherapies to selectively reverse breathing suppression produced by opioids

National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) Synopsis 1

Letter of Intent Due: 30 days prior to due date

Application Due: May 25, 2020 (5:00 PM local to applicant organization)

National Cancer Institute (NCI) invites applications to address any of the broad areas of cancer research, including (but not limited to) cancer biology, cancer prevention, cancer diagnosis, cancer treatment, and cancer control. Basic, translational, clinical, and/or population-based studies in all of these research areas are appropriate.

Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional)

Letter of Intent Due: 30 days prior to application due date

Application Due: May 27, 2020

This funding is designed to support highly integrated research teams of three to six PDs/PIs to address ambitious and challenging research questions that are important for the mission of National Institute of General Medical Sciences (NIGMS) and are beyond the scope of one or two investigators

Childhood Asthma in Urban Settings -Clinical Research Centers (U01 Clinical Trial Optional)

Letter of Intent Due: 30 days prior to application due date

Application Due: June 19, 2020

The purpose of this funding opportunity is to solicit applications for the NIAID Childhood Asthma in Urban Settings Clinical Research Network Clinical Research Centers (CAUSE-CRCs). The CAUSE-CRCs will conduct both network-wide and site-specific clinical studies and trials with the ultimate goal of developing effective asthma treatment or prevention approaches applicable to children residing in low-income urban settings.